These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis. Dhib-Jalbut S Neurology; 2007 May; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563 [TBL] [Abstract][Full Text] [Related]
3. The cellular and molecular events of central nervous system remyelination. Dubois-Dalcq M; Armstrong R Bioessays; 1990 Dec; 12(12):569-76. PubMed ID: 2080911 [TBL] [Abstract][Full Text] [Related]
4. Clonal expansions of pathogenic CD8+ effector cells in the CNS of myelin mutant mice. Leder C; Schwab N; Ip CW; Kroner A; Nave KA; Dornmair K; Martini R; Wiendl H Mol Cell Neurosci; 2007 Nov; 36(3):416-24. PubMed ID: 17889554 [TBL] [Abstract][Full Text] [Related]
5. Homogeneity of active demyelinating lesions in established multiple sclerosis. Breij EC; Brink BP; Veerhuis R; van den Berg C; Vloet R; Yan R; Dijkstra CD; van der Valk P; Bö L Ann Neurol; 2008 Jan; 63(1):16-25. PubMed ID: 18232012 [TBL] [Abstract][Full Text] [Related]
7. The oligodendroglial cell: biology and immunology and relationship to multiple sclerosis. Bartlett PF; Mackay IR J Clin Lab Immunol; 1983 May; 11(1):1-7. PubMed ID: 6348293 [TBL] [Abstract][Full Text] [Related]
8. Oligodendrocyte/myelin injury and repair as a function of the central nervous system environment. Antel J Clin Neurol Neurosurg; 2006 Mar; 108(3):245-9. PubMed ID: 16384636 [TBL] [Abstract][Full Text] [Related]
9. Spreading of autoimmunity from central to peripheral myelin: two cases of clinical association between multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. Falcone M; Scalise A; Minisci C; Romito D; Cancelli I; Gigli GL Neurol Sci; 2006 Apr; 27(1):58-62. PubMed ID: 16688601 [TBL] [Abstract][Full Text] [Related]
12. Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis. Mastronardi FG; Moscarello MA J Neurosci Res; 2005 May; 80(3):301-8. PubMed ID: 15704220 [TBL] [Abstract][Full Text] [Related]
13. Serum antimyelin factors in experimental allergic encephalomyelitis and multiple sclerosis. Seil FJ; Agrawal HC Prog Clin Biol Res; 1984; 146():199-206. PubMed ID: 6201891 [No Abstract] [Full Text] [Related]
14. To look for a needle in a haystack: the search for autoantibodies in multiple sclerosis. Schirmer L; Srivastava R; Hemmer B Mult Scler; 2014 Mar; 20(3):271-9. PubMed ID: 24589684 [TBL] [Abstract][Full Text] [Related]
17. Antibodies to oligodendroglia in patients with multiple sclerosis. Abramsky O; Lisak RP; Silberberg DH; Pleasure DE N Engl J Med; 1977 Dec; 297(22):1207-11. PubMed ID: 335246 [TBL] [Abstract][Full Text] [Related]
18. Central nervous system myelin: structure, synthesis and assembly. Aggarwal S; Yurlova L; Simons M Trends Cell Biol; 2011 Oct; 21(10):585-93. PubMed ID: 21763137 [TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion. Raine CS; Scheinberg L; Waltz JM Lab Invest; 1981 Dec; 45(6):534-46. PubMed ID: 7321526 [TBL] [Abstract][Full Text] [Related]
20. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Storch MK; Piddlesden S; Haltia M; Iivanainen M; Morgan P; Lassmann H Ann Neurol; 1998 Apr; 43(4):465-71. PubMed ID: 9546327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]